Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Call for responsible prescribing decisions under cascade
Companion animal vets observed the conflict most with prescriptions for dogs, rabbits and cats.
Survey reveals concern some decisions could exacerbate AMR

Ahead of World Antibiotic Awareness Day (18 November), the BVA and the VMD are highlighting to vets the importance of making responsible prescribing decisions under the cascade.

The advice comes after BVA’s Voice of the Veterinary Profession’s survey revealed that 60 per cent of vets felt that unquestioningly using the cascade could result in decisions that did not meet the criteria for responsible prescribing.

The survey also found the perceived conflict is apparent across all major practice specialisms. Large animals vets were much less likely to identify it, however, with only 41 per cent observing the issue and 24 per cent seeing it often or sometimes.  

Companion animal vets observed the conflict most with prescriptions for dogs, rabbits and cats, while large animal and mixed practice vets observed it most with cattle and sheep. Mixed practice vets said they also experienced it with prescribing decisions for exotics too.

“The cascade provides much-needed flexibility in allowing veterinary surgeons to treat animals in situations where a licensed product for a condition in a particular species is not available in the UK, but we are concerned that it could in some circumstances lead to decisions that could exacerbate antimicrobial resistance,” said BVA president Simon Doherty.
 
“While there is a legislative requirement to use a UK-authorised veterinary medicine before applying the cascade, there is concern among our members that there are instances where following the procedure could lead to inappropriate prescribing decisions. This is especially true when vets are trying to balance the use of the cascade with the responsible use of critically important antibiotics.
 
He continued: “With antibiotic resistance a very real and urgent concern, our message to vets is to continue to use their professional judgement, on a case-by-case basis, in considering alternative prescribing options, after giving full consideration to potential risks. A commitment from each of us within the veterinary profession to maintain the highest standards of stewardship in using antimicrobials, most especially CIAs, is the only way we can preserve these essential medicines for future generations.”

 

Become a member or log in to add this story to your CPD history

Greyhound Board announces change to vaccination guidance

News Story 1
 The Greyhound Board of Great Britain has published new vaccination guidance, with all greyhounds registered from 1 January, 2027 required to have the L4 leptospirosis vaccination, rather than L2.

The change comes in response to the reduced availability of the 'L2' Leptospirosis vaccine across the UK, and aims to support best biosecurity practice across the racing greyhound population.

GBGB veterinary director Simon Gower, said "While rare, Leptospirosis is a serious infectious disease that can affect both dogs and humans, so it is vital that we offer our greyhounds the broadest possible protection.  

Click here for more...
News Shorts
Free webinar explores congenital heart disease in dogs

A free webinar is to provide veterinary professionals, dog breeders and pet owners an new insights into congenital heart disease.

Chris Linney, a cardiology specialist and Veterinary Cardiovascular Society (VSC) member, will present the webinar from 7.00pm to 8.30pm on Wednesday, 12 November.

Dr Linney will explore the types, causes and clinical presentation of congenital heart conditions. This will include diagnostic approaches, treatment pathways and emerging research opportunities.

The session is the third to be organised by The Kennel Club, with the VCS, following an introductory webinar and a talk on acquired heart disease. Dr Linney's webinar consists of a one-hour presentation, followed by a 30-minute question and answer session.

Dr Linney said: "This webinar will be an opportunity to deepen understanding - not just of the diseases themselves, but of how breeders, vets and owners can work together to support affected dogs and improve outcomes for future generations."

Click here to register for the webinar.